Latest Financials News

Mach7 Technologies reports a modest rise in recurring revenue alongside a comprehensive commercial transformation, positioning itself for growth in AI-driven medical imaging.

Top End Energy has unveiled a significant prospective hydrogen resource in Kansas and strengthened its U.S. market presence with new OTCQB listings, while advancing strategic discussions in Australia’s Beetaloo Basin.

Antilles Gold advances its Cuban mining ambitions with a binding EPC contract signed and construction slated to begin early next year at the Nueva Sabana copper-gold project.

Jindalee Lithium reported a challenging quarter with over A$2 million in cash outflows but bolstered its funding position with a recent $8 million share placement, extending its operational runway.

Jindalee Lithium is progressing its McDermitt Lithium Project with a proposed US SPAC listing, government backing, and an $8 million capital raise, positioning it as a key player in the US critical minerals landscape.

Polymetals Resources Ltd has had its trading suspension lifted following an announcement about a serious safety incident at its Endeavor Mine Site, raising questions about operational impacts and regulatory responses.

Australian Gold and Copper Ltd has significantly expanded its South Cobar exploration footprint through key acquisitions and reported strong high-grade drilling results at its Achilles deposit, underpinning its growth strategy.

Polymetals Resources has reported a fatal underground incident at its Endeavor Mine in NSW, resulting in two deaths and a suspension of operations as investigations proceed.

Aspermont Limited reports its 37th consecutive quarter of subscription growth, launching its Mining-IQ AI platform and securing a landmark $550k contract with Rio Tinto.

Solis Minerals reports encouraging assay results from its Peruvian copper-gold projects alongside a $5.9 million capital raise to accelerate exploration and acquisition activities.

Percheron Therapeutics reports encouraging phase I clinical results for HMBD-002, confirming safety and early efficacy signals, while gearing up for a multi-arm phase II trial in 2026.

Mach7 Technologies reports a pivotal first quarter for FY26, marked by the initial go-live of a major U.S. Veterans Health Administration contract, leadership changes, and a strategic business reset.